Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-23 6:22 pm Sale | 2023-12-31 | 13G | SPYRE THERAPEUTICS, INC SYRE | venBio Select Advisor LLC | 1,839,138 5.100% | -286,459 (-13.48%) | Filing History |
| 2024-02-14 09:25 am Purchase | 2023-12-31 | 13G | KRYSTAL BIOTECH INC KRYS | venBio Select Advisor LLC | 2,565,555 9.100% | 1,155,555 (+81.95%) | Filing History |
| 2024-02-14 09:23 am Purchase | 2023-12-31 | 13G | APELLIS PHARMACEUTICALS INC CO APLS | venBio Select Advisor LLC | 13,411,111 9.900% | 2,786,111 (+26.22%) | Filing History |
| 2024-02-14 09:22 am Purchase | 2023-12-31 | 13G | AMICUS THERAPEUTICS INC FOLD | venBio Select Advisor LLC | 27,400,000 9.300% | 600,000 (+2.24%) | Filing History |
| 2024-02-14 09:21 am Purchase | 2023-12-31 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | venBio Select Advisor LLC | 2,288,888 9.900% | 628,888 (+37.88%) | Filing History |
| 2024-02-14 09:20 am Sale | 2023-12-31 | 13G | MERSANA THERAPEUTICS INC MRSN | venBio Select Advisor LLC | 0 0.000% | -302,000 (Position Closed) | Filing History |
| 2024-02-14 09:18 am Sale | 2023-12-31 | 13G | PMV PHARMACEUTICALS INC PMVP | venBio Select Advisor LLC | 0 0.000% | -3,060,000 (Position Closed) | Filing History |
| 2024-02-14 09:17 am Purchase | 2023-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | venBio Select Advisor LLC | 3,755,555 6.500% | 655,555 (+21.15%) | Filing History |
| 2024-02-14 09:15 am Sale | 2023-12-31 | 13G | KYMERA THERAPEUTICS INC KYMR | venBio Select Advisor LLC | 3,775,000 6.800% | -75,000 (-1.95%) | Filing History |
| 2024-02-14 09:14 am Purchase | 2023-12-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | venBio Select Advisor LLC | 4,535,000 9.100% | 210,000 (+4.86%) | Filing History |
| 2024-02-14 09:13 am Sale | 2023-12-31 | 13G | MIRATI THERAPEUTICS INC MRTX | venBio Select Advisor LLC | 4,886,840 7.000% | -668,715 (-12.04%) | Filing History |
| 2024-02-14 09:12 am Purchase | 2023-12-31 | 13G | XENON PHARMACEUTICALS INC XENE | venBio Select Advisor LLC | 5,666,666 7.700% | 766,666 (+15.65%) | Filing History |
| 2024-02-14 09:10 am Purchase | 2023-12-31 | 13G | VERRICA PHARMACEUTICALS INC VRCA | venBio Select Advisor LLC | 658,333 9.990% | 658,333 (New Position) | Filing History |
| 2024-02-14 09:09 am Purchase | 2023-12-31 | 13G | CYMABAY THERAPEUTICS INC CBAY | venBio Select Advisor LLC | 16,337,739 9.990% | 3,537,739 (+27.64%) | Filing History |
| 2024-02-14 09:08 am Purchase | 2023-12-31 | 13G | SPYRE THERAPEUTICS, INC SYRE | venBio Select Advisor LLC | 2,125,597 5.900% | 2,125,597 (New Position) | Filing History |
| 2024-02-14 09:07 am Purchase | 2023-12-31 | 13G | STRUCTURE THERAPEUTICS INC SPO GPCR | venBio Select Advisor LLC | 6,999,999 5.000% | 6,999,999 (New Position) | Filing History |
| 2024-02-14 09:05 am Sale | 2023-12-31 | 13G | UNITED THERAPEUTICS CORP UTHR | venBio Select Advisor LLC | 2,858,888 6.100% | -6,112 (-0.21%) | Filing History |
| 2024-02-14 09:04 am Unchanged | 2023-12-31 | 13G | MARINUS PHARMACEUTICALS INC MRNS | venBio Select Advisor LLC | 3,150,000 5.800% | 0 (Unchanged) | Filing History |
| 2024-02-14 09:02 am Purchase | 2023-12-31 | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | venBio Select Advisor LLC | 13,050,000 6.400% | 13,050,000 (New Position) | Filing History |
| 2024-02-14 09:00 am Sale | 2023-12-31 | 13G | IO BIOTECH INC IOBT | venBio Select Advisor LLC | 0 0.000% | -2,055,883 (Position Closed) | Filing History |